CN103393913B - Chinese medicinal composition for treating uterine prolapse - Google Patents
Chinese medicinal composition for treating uterine prolapse Download PDFInfo
- Publication number
- CN103393913B CN103393913B CN201310329485.4A CN201310329485A CN103393913B CN 103393913 B CN103393913 B CN 103393913B CN 201310329485 A CN201310329485 A CN 201310329485A CN 103393913 B CN103393913 B CN 103393913B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- uterine prolapse
- herba
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010046814 Uterine prolapse Diseases 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 34
- 229940079593 drugs Drugs 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 108010052008 colla corii asini Proteins 0.000 claims description 7
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 5
- 235000016993 Agrimonia Nutrition 0.000 claims description 5
- 241000605447 Anemarrhena Species 0.000 claims description 5
- 241000245240 Lonicera Species 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 241000238370 Sepia Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 240000003301 Agrimonia eupatoria Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000486 side effect Toxicity 0.000 abstract description 5
- 229940107666 ASTRAGALUS ROOT Drugs 0.000 abstract 1
- 240000001992 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 235000010696 Leonuro Nutrition 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 240000001313 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000157491 Morinda Species 0.000 abstract 1
- 240000001754 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 241001092084 Agrimonia Species 0.000 description 4
- 210000004291 Uterus Anatomy 0.000 description 3
- 210000001215 Vagina Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 1
- 210000003679 Cervix Uteri Anatomy 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000003628 erosive Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Abstract
The invention relates to a Chinese medicinal composition for treating uterine prolapse. The Chinese medicinal composition is prepared from the following crude drugs in parts by weight: 15-25 parts of motherwort, 15-25 parts of fructus aurantii, 10-20 parts of codonopsis pilosula, 10-20 parts of astragalus root, 10-20 parts of rhizoma anemarrhenae, 10-15 parts of tuckahoe, 10-15 parts of donkey-hide gelatin, 10-15 parts of morinda offcinalis how, 6-12 parts of herba agrimoniae, 6-12 parts of prepared rehmannia root, 6-12 parts of angelica, 6-12 parts of rhizoma cimicifugae foetidae, 3-9 parts of herba taxilli, 3-9 parts of cuttle-bone, 3-9 parts of honeysuckle, 3-9 parts of wolfberry fruit, 3-9 parts of eucommia bark, 3-9 parts of dried orange peel, 3-9 parts of radix bupleuri and 3-9 parts of prepared liquorice root. The Chinese medicinal composition has the advantages of stable curative effect, short treatment time and small side effect.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of uterine prolapse.
Background technology
Uterine prolapse refers to that uterus declines along vagina from normal position, and it is below horizontal that the external os of vervix reaches ischial spine, and even uterus all emerges in outside vaginal orifice.Clinical manifestation: bearing down and the soreness of waist; The swollen thing of vagina is deviate from, and deviates from first in the time that abdominal pressure increases, and severe patient can not also be received, and erosion can occur in long-term friction; Urinate or difficult defecation; Check and find uterine prolapse.
At present, the medicine for the treatment of uterine prolapse is more, but has the deficiencies such as curative effect is unstable, treatment time is long, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of uterine prolapse, the present invention has advantages of stable curative effect, treatment time is short, side effect is little.
Treat a Chinese medicine composition for uterine prolapse, made by the crude drug of following weight portion: Herba Leonuri 15-25 part, Fructus Aurantii 15-25 part, Radix Codonopsis 10-20 part, Radix Astragali 10-20 part, Rhizoma Anemarrhenae 10-20 part, Poria 10-15 part, Colla Corii Asini 10-15 part, Radix Morindae Officinalis 10-15 part, Herba Agrimoniae 6-12 part, Radix Rehmanniae Preparata 6-12 part, Radix Angelicae Sinensis 6-12 part, Rhizoma Cimicifugae 6-12 part, Herba Taxilli 3-9 part, Endoconcha Sepiae 3-9 part, Flos Lonicerae 3-9 part, Fructus Lycii 3-9 part, Cortex Eucommiae 3-9 part, Pericarpium Citri Reticulatae 3-9 part, Radix Bupleuri 3-9 part, Radix Glycyrrhizae Preparata 3-9 part.
The Chinese medicine composition of described treatment uterine prolapse, it is preferably made up of the crude drug of following weight portion: 20 parts of Herba Leonuris, 20 parts of Fructus Aurantiis, 15 parts of Radix Codonopsis, 15 parts of the Radixs Astragali, 15 parts of the Rhizoma Anemarrhenaes, 12 parts, Poria, 12 parts, Colla Corii Asini, 12 parts of Radix Morindae Officinaliss, 9 parts of Herba Agrimoniaes, 9 parts of Radix Rehmanniae Preparata, 9 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Cimicifugaes, 6 parts of Herba Taxillis, 6 parts of Endoconcha Sepiaes, 6 parts of Flos Loniceraes, 6 parts of Fructus Lycii, 6 parts of the Cortexs Eucommiae, 6 parts of Pericarpium Citri Reticulataes, 6 parts of Radix Bupleuri, 6 parts of Radix Glycyrrhizae Preparatas.
The preparation method of the Chinese medicine composition of described treatment uterine prolapse is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment uterine prolapse in preparation treatment uterine prolapse medicine.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, choose each crude drug and proportioning thereof, there is the function of strengthening spleen, tonifying kidney, benefiting qi and raising yang, nourishing the blood and yin, realize the object for the treatment of uterine prolapse.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats uterine prolapse patient 40 examples altogether, the age is 25-58 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., taking decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 20 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: recover of uterus normal position, do not recur half a year.
Take a turn for the better: cervix uteri and palace body were received to last time, but did not return to normal position.
Do not heal: symptom and sign are unchanged.
(4) therapeutic outcome: the present invention treats uterine prolapse patient 40 examples altogether, through 1-3 course of therapy, cures 31 examples, accounts for 77.5%, and 7 examples that take a turn for the better, account for 17.5%, and 2 examples that do not heal, account for 5%, and effective percentage is 95%, has no any side effect; Cure in 31 examples, cure 15 examples 1 course for the treatment of, cure 9 examples 2 courses for the treatment of, cure 7 examples 3 courses for the treatment of; Result shows, the present invention has advantages of stable curative effect, treatment time is short, side effect is little.
Detailed description of the invention
Embodiment 1:
Treat a Chinese medicine composition for uterine prolapse, made by the crude drug of following weight portion: 20 parts of Herba Leonuris, 20 parts of Fructus Aurantiis, 15 parts of Radix Codonopsis, 15 parts of the Radixs Astragali, 15 parts of the Rhizoma Anemarrhenaes, 12 parts, Poria, 12 parts, Colla Corii Asini, 12 parts of Radix Morindae Officinaliss, 9 parts of Herba Agrimoniaes, 9 parts of Radix Rehmanniae Preparata, 9 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Cimicifugaes, 6 parts of Herba Taxillis, 6 parts of Endoconcha Sepiaes, 6 parts of Flos Loniceraes, 6 parts of Fructus Lycii, 6 parts of the Cortexs Eucommiae, 6 parts of Pericarpium Citri Reticulataes, 6 parts of Radix Bupleuri, 6 parts of Radix Glycyrrhizae Preparatas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for uterine prolapse, made by the crude drug of following weight portion: 15 parts of Herba Leonuris, 15 parts of Fructus Aurantiis, 10 parts of Radix Codonopsis, 10 parts of the Radixs Astragali, 10 parts of the Rhizoma Anemarrhenaes, 10 parts, Poria, 10 parts, Colla Corii Asini, 10 parts of Radix Morindae Officinaliss, 6 parts of Herba Agrimoniaes, 6 parts of Radix Rehmanniae Preparata, 6 parts of Radix Angelicae Sinensis, 6 parts of Rhizoma Cimicifugaes, 3 parts of Herba Taxillis, 3 parts of Endoconcha Sepiaes, 3 parts of Flos Loniceraes, 3 parts of Fructus Lycii, 3 parts of the Cortexs Eucommiae, 3 parts of Pericarpium Citri Reticulataes, 3 parts of Radix Bupleuri, 3 parts of Radix Glycyrrhizae Preparatas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for uterine prolapse, made by the crude drug of following weight portion: 25 parts of Herba Leonuris, 25 parts of Fructus Aurantiis, 20 parts of Radix Codonopsis, 20 parts of the Radixs Astragali, 20 parts of the Rhizoma Anemarrhenaes, 15 parts, Poria, 15 parts, Colla Corii Asini, 15 parts of Radix Morindae Officinaliss, 12 parts of Herba Agrimoniaes, 12 parts of Radix Rehmanniae Preparata, 12 parts of Radix Angelicae Sinensis, 12 parts of Rhizoma Cimicifugaes, 9 parts of Herba Taxillis, 9 parts of Endoconcha Sepiaes, 9 parts of Flos Loniceraes, 9 parts of Fructus Lycii, 9 parts of the Cortexs Eucommiae, 9 parts of Pericarpium Citri Reticulataes, 9 parts of Radix Bupleuri, 9 parts of Radix Glycyrrhizae Preparatas.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (4)
1. a Chinese medicine composition for the treatment of uterine prolapse, is characterized in that: the crude drug by following weight portion is made: Herba Leonuri 15-25 part, Fructus Aurantii 15-25 part, Radix Codonopsis 10-20 part, Radix Astragali 10-20 part, Rhizoma Anemarrhenae 10-20 part, Poria 10-15 part, Colla Corii Asini 10-15 part, Radix Morindae Officinalis 10-15 part, Herba Agrimoniae 6-12 part, Radix Rehmanniae Preparata 6-12 part, Radix Angelicae Sinensis 6-12 part, Rhizoma Cimicifugae 6-12 part, Herba Taxilli 3-9 part, Endoconcha Sepiae 3-9 part, Flos Lonicerae 3-9 part, Fructus Lycii 3-9 part, Cortex Eucommiae 3-9 part, Pericarpium Citri Reticulatae 3-9 part, Radix Bupleuri 3-9 part, Radix Glycyrrhizae Preparata 3-9 part.
2. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, is characterized in that: the crude drug by following weight portion is made: 20 parts of Herba Leonuris, 20 parts of Fructus Aurantiis, 15 parts of Radix Codonopsis, 15 parts of the Radixs Astragali, 15 parts of the Rhizoma Anemarrhenaes, 12 parts, Poria, 12 parts, Colla Corii Asini, 12 parts of Radix Morindae Officinaliss, 9 parts of Herba Agrimoniaes, 9 parts of Radix Rehmanniae Preparata, 9 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Cimicifugaes, 6 parts of Herba Taxillis, 6 parts of Endoconcha Sepiaes, 6 parts of Flos Loniceraes, 6 parts of Fructus Lycii, 6 parts of the Cortexs Eucommiae, 6 parts of Pericarpium Citri Reticulataes, 6 parts of Radix Bupleuri, 6 parts of Radix Glycyrrhizae Preparatas.
3. the preparation method of the Chinese medicine composition for the treatment of uterine prolapse according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of uterine prolapse according to claim 1 and 2 in preparation treatment uterine prolapse medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310329485.4A CN103393913B (en) | 2013-07-26 | 2013-07-26 | Chinese medicinal composition for treating uterine prolapse |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310329485.4A CN103393913B (en) | 2013-07-26 | 2013-07-26 | Chinese medicinal composition for treating uterine prolapse |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103393913A CN103393913A (en) | 2013-11-20 |
| CN103393913B true CN103393913B (en) | 2014-12-17 |
Family
ID=49557766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310329485.4A Expired - Fee Related CN103393913B (en) | 2013-07-26 | 2013-07-26 | Chinese medicinal composition for treating uterine prolapse |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103393913B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103611144B (en) * | 2013-12-15 | 2015-07-08 | 徐士杰 | Medicine for treating uterine prolapse and preparation method thereof |
| CN104274612A (en) * | 2014-09-19 | 2015-01-14 | 于建敏 | Traditional Chinese medicinal preparation for treating damp-heat type uterine prolapse |
| CN105521200A (en) * | 2014-09-28 | 2016-04-27 | 张红伶 | Uterine prolapse treating drug |
| CN105343740A (en) * | 2015-12-18 | 2016-02-24 | 徐士杰 | Medicine for treating uterine prolapse and preparation method of medicine |
| CN105560994A (en) * | 2016-01-21 | 2016-05-11 | 汤华淑 | Traditional Chinese medicine composition for treating prolapse of uterus |
| CN105853782A (en) * | 2016-04-12 | 2016-08-17 | 汤华淑 | Traditional Chinese medicinal composition for treating uterine prolapsed |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| CN1336219A (en) * | 2001-08-21 | 2002-02-20 | 徐凤玉 | Gynopathy treating traditional Chinese medicine |
-
2013
- 2013-07-26 CN CN201310329485.4A patent/CN103393913B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| CN1336219A (en) * | 2001-08-21 | 2002-02-20 | 徐凤玉 | Gynopathy treating traditional Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103393913A (en) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN103356961B (en) | Traditional Chinese medicinal composition for treating amenorrhoea | |
| CN103330809B (en) | Traditional Chinese medicine composition for curing functional uterine bleeding | |
| CN103933353A (en) | Medicament for treating rheumatism and gout | |
| CN101385828B (en) | Traditional Chinese medicine for treating urgent and chronic inflammation of upper respiratory tract | |
| CN103356916B (en) | Traditional Chinese medicinal composition for treating retrograde menstruation | |
| CN103330920B (en) | Traditional Chinese medicine composition for curing oviduct obstruction | |
| CN103356857A (en) | Traditional Chinese medicine composition for treating threatened abortion | |
| CN103393966A (en) | Chinese medicinal composition for treating irregular menstruation | |
| CN103830454A (en) | Traditional Chinese medicine composition for treating postpartum urinary retention | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN102895606A (en) | Analgesic balm and preparation method thereof | |
| CN104645146A (en) | Chinese medicine composition for treating acne | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN102526635B (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN104027461A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN103330928B (en) | Traditional Chinese medicine composition used for treating gastric ulcer and preparation method thereof | |
| CN104524508A (en) | Traditional Chinese medicine for treating peptic ulcer and preparation method thereof | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN103356925A (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN103341025B (en) | Traditional Chinese medicine composition for treating premature ejaculation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Juan Inventor after: Wang Li Inventor before: Huang Shujuan |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160805 Address after: 261000 No. 13, culture street, Hanting District, Shandong, Weifang Patentee after: Wang Juan Address before: B ultrasonic room, Wuhe County Hospital and 233300 Mo He Kou Zhen Anhui city of Bengbu Province Patentee before: Huang Shujuan |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 Termination date: 20170726 |